Journal of Neurology and Neurorehabilitation Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article - Journal of Neurology and Neurorehabilitation Research (2024) Volume 9, Issue 5

The Role of Pediatric Neurology in Managing Neurodegenerative Diseases in Childhood

Eugenio Vlodavets *

Department of Developmental Neurology, Medical University of Gda?sk, Poland

*Corresponding Author:
Eugenio Vlodavets
Department of Developmental Neurology, Medical University of Gda?sk, Poland
E-mail: eugeniov@mug.pl.in

Received: 24-Aug-2024, Manuscript No. JNNR-24-150911; Editor assigned: 26-Aug-2024, PreQC No. JNNR-24-150911(PQ); Reviewed: 09-Sep-2024, QC No. JNNR-24-150911; Revised: 14-Sep-2024, Manuscript No. JNNR-24-150911(R); Published: 21-Sep-2024, DOI: 10.35841/aajnnr-9.5.230

Citation: : Vlodavets E. The Role of Pediatric Neurology in Managing Neurodegenerative Diseases in Childhood. J Neurol Neurorehab Res.2024;9(5):230

Introduction

Pediatric neurology plays a crucial role in the diagnosis, treatment, and management of neurodegenerative diseases in children. These conditions, which involve the progressive loss of function in the nervous system, can have devastating impacts on a child’s physical and cognitive abilities [1]. Some common neurodegenerative diseases in children include Tay-Sachs disease, Batten disease, spinal muscular atrophy (SMA), and certain types of leukodystrophies. Given the complexity of these disorders and their progression over time, pediatric neurologists are vital in providing specialized care tailored to each child’s unique condition [2].

Early diagnosis is a key aspect of managing neurodegenerative diseases. Many of these conditions are genetic, meaning symptoms may begin manifesting early in a child’s life, although the onset and severity can vary [3]. Pediatric neurologists often begin with comprehensive clinical evaluations, including detailed medical histories, physical examinations, and neurological assessments to detect early signs of these disorders [4]. In many cases, genetic testing and advanced imaging techniques such as magnetic resonance imaging (MRI) or computed tomography (CT) scans are employed to aid in diagnosis. Identifying these diseases early allows for timely intervention, which may slow disease progression or alleviate symptoms [5].

Once diagnosed, pediatric neurologists focus on developing individualized treatment plans aimed at managing symptoms, preserving function, and improving the child’s quality of life. While many neurodegenerative diseases have no cure, certain treatments can help manage symptoms and support the child’s developmental needs [6]. For instance, children with spinal muscular atrophy may benefit from gene therapies like nusinersen, which can slow disease progression by targeting the underlying genetic cause. For other conditions like Batten disease, symptomatic treatments, including medications to control seizures or manage movement difficulties, are often a key part of the care plan [7].

In addition to medical interventions, pediatric neurologists often work alongside a team of specialists, including physical therapists, occupational therapists, and speech therapists, to address the full spectrum of a child’s needs. These interdisciplinary approaches are essential in maintaining mobility, cognitive function, and overall quality of life for as long as possible [8].

Family support is another important element of pediatric neurology care. Parents and caregivers face immense emotional and practical challenges when caring for a child with a neurodegenerative disease [9]. Pediatric neurologists provide not only medical guidance but also emotional support and resources, helping families navigate the complexities of their child’s condition. By coordinating care, providing access to clinical trials, and offering education, pediatric neurologists play a vital role in managing these life-altering diseases [10].

Conclusion

Pediatric neurology is integral to the comprehensive management of neurodegenerative diseases in children. By providing early diagnosis, tailored treatment plans, and ongoing support, pediatric neurologists significantly impact the quality of life for affected children and their families. The collaborative efforts of neurologists, allied health professionals, and families are essential in addressing the multifaceted needs of children with neurodegenerative diseases. Through this holistic approach, pediatric neurology not only aims to manage symptoms and slow disease progression but also to empower families and enhance the overall well-being of children facing these complex conditions.

References

  1. Helen AH, Burne R. Medical and nursing problems of children with neurodegenerative disease. Palliat Med. 1995;9(1):19-26.

    2. Indexed at, Google Scholar, Cross Ref

  2. Dallara A, Meret A, Saroyan J. Mapping the literature: palliative care within adult and child neurology. J Child Neurol. 2014;29(12):1728-38.

    3. Indexed at, Google Scholar, Cross Ref

  3. Ward DI, Saifeddine M, Gogoi M. Novel treatments for neurodegenerative disorders predominantly presenting in children and young adults. Neurological disorders. 2024:523-534.

    4. Google Scholar

  4. Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA. 2005;294(24):3131-4.

    5. Indexed at, Google Scholar, Cross Ref

  5. Shevell M. The role of the pediatric neurologist in the care of children with neurodevelopmental disabilities. Pediatric Neurology. 2018;88:3-9.

    6. Indexed at, Google Scholar, Cross Ref

  6. Amato ME, Darling A, Stovickova L, et al. Improving paediatric movement disorders care: Insights on rating scales utilization and clinical practice. Eur J Paediatr Neurol. 2024;52:10-9.

    7. Indexed at, Google Scholar, Cross Ref

  7. Ahmad Bhat S, Amjad Kamal M, Sastry Yarla N, et al. Synopsis on managment strategies for neurodegenerative disorders: Challenges from bench to bedside in successful drug discovery and development. Curr Top Med Chem. 2017;17(12):1371-8.

    8. Indexed at, Google Scholar, Cross Ref

  8. Malhotra S, Asis A, Glaze D. Transition of Sleep Care in Patients with Neuromuscular and Neurodegenerative Disorders. Transitioning sle. 2023:225-246.

    9. Google Scholar

  9. Fay A. Spinal muscular atrophy: A (now) treatable neurodegenerative disease. Pediatr Clin North Am. 2023;70(5):963-77.

    10. Indexed at, Google Scholar, Cross Ref

  10. Koy A, Lin JP, Sanger TD, et al. Advances in management of movement disorders in children. Lancet Neurol. 2016;15(7):719-35.

    11. Indexed at, Google Scholar, Cross Ref

Get the App